Abterra Bio is enabling the next-generation of antibody therapeutics. Our technologies use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response to challenge. We give our partners access to every relevant antibody to meet their project goals. Find out what service might be right for you with our service guide: https://abterrabio.com/service-guide/
Abterra Bio began life as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna are professors in the Computer Science and Engineering Department and leading researchers in bioinformatics. Their expertise forms the algorithmic foundation upon which our products and services are built.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 11588 Sorrento Valley Rd,
- Industry
- Biotechnology
- Website
- https://abterrabio.com
- Keywords
- Proteomics, Bioinformatics, Mass spectrometry, Antibody sequencing, Proteogenomics, Antibody discovery, Metabolomics.
- HQ
- San Diego, California
Abterra Biosciences Questions
Abterra Biosciences's website is https://abterrabio.com
Abterra Biosciences's LinkedIn profile is https://www.linkedin.com/company/abterra-bio
Abterra Biosciences has
12 employees.
View email and phone details for 12
employees at Abterra Biosciences.
Abterra Biosciences's industry is
Biotechnology
Abterra Biosciences's top competitors are
Escient Pharmaceuticals,
Probius,
Belharra Therapeutics,
Poseida Therapeutics, Inc.,
Abintus Bio, Inc.,
Infixion Bioscience, Inc.,
Adarx Pharmaceuticals Inc.,
Crinetics Pharmaceuticals,
Inhibrx Biosciences, Inc.,
Xellar Biosystems.
Abterra Biosciences's categories are Biotechnology
Abterra Biosciences's founding year is 2009
